chartexchange

Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates

GlobeNewswire Inc. | Nov 5, 2026 7:00 AM EST

Phase 3 SONATA-HCM study substantially overenrolled; top-line data expected Q1 2027

Read original article